Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
Top Cited Papers
Open Access
- 18 April 2013
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1), 108
- https://doi.org/10.1186/1741-7015-11-108
Abstract
Testosterone therapy is increasingly promoted. No randomized placebo-controlled trial has been implemented to assess the effect of testosterone therapy on cardiovascular events, although very high levels of androgens are thought to promote cardiovascular disease.Keywords
This publication has 105 references indexed in Scilit:
- Large-scale association analysis identifies new risk loci for coronary artery diseaseNature Genetics, 2012
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyThe Lancet Oncology, 2012
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2011
- Testosterone therapy increased muscle mass and lipid oxidation in aging menAGE, 2011
- Adverse Events Associated with Testosterone AdministrationNew England Journal of Medicine, 2010
- Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2010
- Effects of Transdermal Testosterone on Bone and Muscle in Older Men with Low Bioavailable Testosterone Levels, Low Bone Mass, and Physical FrailtyJournal of the American Geriatrics Society, 2010
- Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2010
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008